Dr. Matthew Mccarty

Overview

Dr. Matthew Mccarty, MD, is a Hematology/Oncology specialist in Knoxville, Tennessee. He attended and graduated from Case Western Reserve University School Of Medicine in 1988, having over 36 years of diverse experience, especially in Hematology/Oncology. He is affiliated with many hospitals including Blount Memorial Hospital, Fort Loudoun Medical Center, Fort Sanders Regional Medical Center, Parkwest Medical Center, Sweetwater Hospital Association. Dr. Matthew Mccarty also cooperates with other doctors and physicians in medical groups including Thompson Oncology Group. Dr. Matthew Mccarty accepts Medicare-approved amount as payment in full. Call (865) 541-1720 to request Dr. Matthew Mccarty the information (Medicare information, advice, payment, ...) or simply to book an appointment.

Doctor Profile

Quality Reporting

• eRx - He does not participate in the Medicare Electronic Prescribing (eRx) Incentive Program.
• PQRS - He does not report Quality Measures (PQRS). The Physician Quality Reporting System (PQRS) is a Medicare program encouraging health care professionals and group practices to report information on their quality of care. Quality measures can show how well a health care professional provides care to people with Medicare.
• EHR - He does not use electronic health records (EHR). The Electronic Health Records (EHR) Incentive Program encourages health care professionals to use certified EHR technology in ways that may improve health care. Electronic health records are important because they may improve a health care professional's ability to make well-informed treatment decisions.
• MHI - He does not commit to heart health through the Million Hearts initiative. Million Hearts is a national initiative that encourages health care professionals to report and perform well on activities related to heart health in an effort to prevent heart attacks and strokes.
• MOC - He does not participate in the Medicare Maintenance of Certification Program. A "Maintenance of Certification Program" encourages board certified physicians to continue learning and self-evaluating throughout their medical career.

Language Spoken by Dr. Matthew Mccarty

• English

Medical Licenses

Specialization	License Number	Issued State
Internal Medicine / Hematology & Oncology click for detail Hematology & Oncology An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.	30053	Tennessee

Affiliated Hospitals

Hospital Name	Location	Hospital Type	Hospital Ownership
Blount Memorial Hospital	Maryville, Tennessee	Acute Care Hospitals	Government - Local
Fort Loudoun Medical Center	Lenoir City, Tennessee	Acute Care Hospitals	Voluntary Non-Profit - Other
Fort Sanders Regional Medical Center	Knoxville, Tennessee	Acute Care Hospitals	Voluntary Non-Profit - Private
Parkwest Medical Center	Knoxville, Tennessee	Acute Care Hospitals	Voluntary Non-Profit - Private
Sweetwater Hospital Association	Sweetwater, Tennessee	Acute Care Hospitals	Voluntary Non-Profit - Private

Medical Group Practice

Doing Business As	Legal Organization Name	Number of members
Thompson Oncology Group	Thompson Oncology Group	22

Practice Locations

This doctor profile was updated by using the public dataset from Centers for Medicare and Medicaid Services (CMS) which is publicized on Thursday, October 8, 2015, and correspondent NPI information on the public NPPES record dated Tuesday, June 29, 2010. If you found out that something incorrect and want to change it, please follow this Update Data guide.

Contact Dr. Matthew Mccarty by phone: (865) 541-1720 for verification, detailed information, or booking an appointment before going to.

See more related doctors and physicians

Reviews

Dr. Matthew Mccarty [NPI: 1184694333]Hematology/Oncology, Medical Oncology